Press Releases WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Market Closed - Hong Kong S.E. Other stock markets 04:09:05 2024-06-07 am EDT			5-day change	1st Jan Change
11.38 ^HKD	-1.56%		+2.15%	-61.55%

Jun. 01	US lawmakers ask FBI for briefing on GenScript Biotech's links to China	RE
May. 31	US lawmakers ask FBI for briefing on GenScript Biotech's links to China	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

WuXi Biologics Enhances Manufacturing Capability with the Installation of Three 5,000L Single-Use Bioreactors	Jun. 06	AQ
WuXi facility boosts bioprocessing capacity with new bioreactors	Jun. 06	AQ
WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment	Apr. 30	PU
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024	Apr. 16	AQ
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories	Apr. 03	AQ
WuXi Biologics Reports Solid 2023 Annual Results	Mar. 27	AQ
WuXi Biologics Named to CDP 'A List' for Water Security	Mar. 25	AQ
WuXi Biologics Cayman : Breaks Ground on CRDMO Center in Singapore	Mar. 19	PU
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment	Mar. 06	AQ
WuXi Biologics Ireland Site Receives Three ISO Certifications	Mar. 04	AQ
WuXi Biologics achieves large-scale manufacturing milestone	Jan. 31	AQ
WuXi Biologics Launches WuXiaADCC PLUSTM for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect	Jan. 26	AQ
WuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBodyTM	Jan. 18	AQ
WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates	Jan. 12	AQ
WUXI BIOLOGICS TO PARTICIAPTE AT 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE	Jan. 10	AQ
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts	Jan. 09	AQ
WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating	Dec. 11	AQ
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of 6 g/L/day at Pilot Scale	Nov. 23	AQ
Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics	Nov. 21	AQ
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange	Nov. 20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Press Releases

Filters